Elliot Norry Adaptimmune Therapeutics PLC (ADAP) insider trading activity
Elliot Norry is Chief Medical Officer of Adaptimmune Therapeutics PLC. Currently has a direct ownership of 19,257 shares of ADAP, which is worth approximately $13,865. The most recent transaction as insider was on Jan 17, 2024, when has been sold 18,276 shares (American Depositary Shares representing Ordinary Shares) at a price of $0.67 per share, resulting in proceeds of $12,244. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
19.3K
0%
3M change
451.62%
12M change
Total Value Held
$13,865
Elliot Norry Transaction History
EN
Elliot Norry
Chief Medical Officer
Abingdon, X0